Gallant is a new and unique regenerative medicine business focusing on helping pets have better, higher-quality lives. Working everyday to advance the field of stem cell therapy to transform the field of veterinary medicine. Building the worlds premier platform for regenerative medicine in animal health, Gallant has generated a pipeline of allogeneic products for four indications. In addition to tradition cell therapy platform, Gallant also has early stage cell therapy platform of "primed" cells that are programmed to drive them toward specific effectiveness outcomes. Partnering with veterinarians and pet parents, Gallant also has the ability to collect and bank young stem cells from the reproductive tissue which would otherwise be discarded during a spay/neuter. These young, potent stem cells are stored for the future when distinct therapies are needed. Gallant opens a new world of wellness opportunity and makes proven regenerative medicine accessible to pets, pet parents and veterinarians.